Sevelamer

Category: Hyperphosphatemia

Sevelamer (rINN) is a phosphate binding medication used to treat hyperphosphatemia in patients with chronic kidney disease. When taken with meals, it binds to dietary phosphate and prevents its absorption. Sevelamer was invented and developed by GelTex Pharmaceuticals. Sevelamer is marketed by Sanofi under the brand names Renagel (sevelamer hydrochloride) and Renvela (sevelamer carbonate). Contents 1 Chemistry and pharmacology 2 Medical uses 3 Contraindications 4 Adverse effects 5 Other eff... [wikipedia]

Dosage List

Sevelamer G447
Sevelamer Hydrochloride 800 mg Oral Tablet, Film Coated
NDC: 60687-449
Labeler:
American Health Packaging
Sevelamer G447
Sevelamer Hydrochloride 800 mg Oral Tablet, Film Coated
NDC: 68462-447
Labeler:
Glenmark Pharmaceuticals Inc., USA
Sevelamer Hydrochloride 800 mg Oral Tablet, Film Coated
NDC: 0955-1048
Labeler:
Winthrop U.S.
Sevelamer Hydrochloride 400 mg Oral Tablet, Film Coated
NDC: 68462-446
Labeler:
Glenmark Pharmaceuticals Inc., USA
Sevelamer Hydrochloride 400 mg Oral Tablet
NDC: 70748-172
Labeler:
Lupin Pharmaceuticals, Inc.
Sevelamer Hydrochloride 800 mg Oral Tablet
NDC: 70748-173
Labeler:
Lupin Pharmaceuticals, Inc.

Related Brands

Drugs with the same active ingredients